Search results
Results from the WOW.Com Content Network
The strongest risk factor for developing asthma is a history of atopic disease; [66] with asthma occurring at a much greater rate in those who have either eczema or hay fever. [80] Asthma has been associated with eosinophilic granulomatosis with polyangiitis (formerly known as Churg–Strauss syndrome), an autoimmune disease and vasculitis. [81]
This is a shortened version of the eighth chapter of the ICD-9: Diseases of the Respiratory System. It covers ICD codes 460 to 519. The full chapter can be found on pages 283 to 300 of Volume 1, which contains all (sub)categories of the ICD-9. Volume 2 is an alphabetical index of Volume 1.
The ICD-9-CM is based on the ICD-9 but provides for additional morbidity detail. It was updated annually on October 1. [15] [16] It consists three volumes: Volumes 1 and 2 contain diagnosis codes. (Volume 1 is a tabular listing, and volume 2 is an index.) Extended for ICD-9-CM
While the acronyms are similar, reactive airway disease (RAD) and reactive airways dysfunction syndrome (RADS) are not the same. [1]Reactive airways dysfunction syndrome was first identified by Stuart M. Brooks and colleagues in 1985 as an asthma-like syndrome developing after a single exposure to high levels of an irritating vapor, fume, or smoke.
(1000F–1505F) Patient history (2000F–2060F) Physical examination (3006F–3776F) Diagnostic/screening processes or results (4000F–4563F) Therapeutic, preventive or other interventions (5005F–5250F) Follow-up or other outcomes (6005F–6150F) Patient safety (7010F–7025F) Structural measures (9001F–9007F) Non-measure claims-based ...
The major criteria are: a persistent airflow limitation (a ratio of forced expiratory volume in 1 second divided by forced vital capacity of less than 0.7 or below the lower limit of normal), a significant exposure history to tobacco smoke (defined as a greater than 10-pack/year history), or significant exposure to other indoor or outdoor air ...
A bronchial challenge test is a medical test used to assist in the diagnosis of asthma. [1] The patient breathes in nebulized methacholine or histamine. Thus the test may also be called a methacholine challenge test or histamine challenge test respectively. Both drugs provoke bronchoconstriction, or narrowing of the airways.
In 1968 Andor Szentivanyi first described The Beta Adrenergic Theory of Asthma; in which blockage of the Beta-2 receptors of pulmonary smooth muscle cells causes asthma. [27] Szentivanyi's Beta Adrenergic Theory is a citation classic [ 28 ] using the Science Citation Index and has been cited more times than any other article in the history of ...